What's Happening?
Faegre Drinker has announced the addition of Jeremiah Kelly and Justin Coen as partners in its government and regulatory affairs practice in Washington, DC. Both Kelly and Coen bring extensive experience in navigating the FDA regulatory framework, assisting
companies from the development stages to post-market compliance. Kelly specializes in working with pharmaceutical, biotechnology, and medical device manufacturers to ensure their products meet FDA regulations and marketplace demands. Coen provides advisory services across the full product life cycle for medical device, pharmaceutical, biotechnology, and animal health companies, focusing on FDA strategy, commercialization, and market expansion. Their move from Venable LLP to Faegre Drinker is seen as a strategic enhancement of the firm's capabilities in regulatory affairs.
Why It's Important?
The addition of Kelly and Coen to Faegre Drinker is significant as it strengthens the firm's expertise in FDA regulatory matters, a critical area for companies in the pharmaceutical and biotechnology sectors. This move is likely to enhance Faegre Drinker's ability to support clients in navigating complex regulatory landscapes, which is crucial for compliance and successful market entry. The expertise of these partners can help clients mitigate risks associated with FDA regulations, potentially leading to faster product approvals and market access. This development underscores the competitive nature of legal services in regulatory affairs, where firms seek to bolster their teams with seasoned experts to better serve their clients' needs.
